Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis-Reference-Cited by-同舟云学术

Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis

Published:2008-01 Issue:1 Volume:123 Page:66-78
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Vandenbark Arthur A.,Culbertson Nicole E.,Bartholomew Richard M.,Huan Jianya,Agotsch Marci,LaTocha Dorian,Yadav Vijayshree,Mass Michele,Whitham Ruth,Lovera Jesus,Milano June,Theofan Georgia,Chou Yuan K.,Offner Halina,Bourdette Dennis N.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2007.02703.x/fullpdf

Reference52 articles.

1. Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+T Cells in Multiple Sclerosis

2. Cross-sectional and longitudinal analysis of myelin-reactive T cells in patients with multiple sclerosis

3. Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene

4. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis

5. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Treatment Options in Pediatric Onset Multiple Sclerosis;Sclerosis;2024-04-01

2. Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis;Clinical & Translational Immunology;2023-01

3. Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis;Frontiers in Immunology;2022-01-05

4. New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates;PLOS ONE;2021-11-02

5. Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients;Frontiers in Immunology;2021-03-22